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Abstract: The Taiwan cobra (Naja naja atra) chymotrypsin inhibitor (NACI) consists of 
57 amino acids and is related to other Kunitz-type inhibitors such as bovine pancreatic 
trypsin inhibitor (BPTI) and Bungarus fasciatus fraction IX (BF9), another chymotrypsin 
inhibitor. Here we present the solution structure of NACI. We determined the NMR 
structure of NACI with a root-mean-square deviation of 0.37 Å for the backbone atoms and 
0.73 Å for the heavy atoms on the basis of 1,075 upper distance limits derived from NOE 
peaks measured in its NOESY spectra. To investigate the structural characteristics of 
NACI, we compared the three-dimensional structure of NACI with BPTI and BF9. The 
structure of the NACI protein comprises one 310-helix, one α-helix and one double-stranded 
antiparallel β-sheet, which is comparable with the secondary structures in BPTI and BF9. 
The RMSD value between the mean structures is 1.09 Å between NACI and BPTI and 1.27 
Å between NACI and BF9. In addition to similar secondary and tertiary structure, NACI 
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might possess similar types of protein conformational fluctuations as reported in BPTI, 
such as Cys14–Cys38 disulfide bond isomerization, based on line broadening of 
resonances from residues which are mainly confined to a region around the Cys14–Cys38 
disulfide bond. 
Keywords: Naja naja atra; snake venom; chymotrypsin inhibitor; NACI; BPTI; NMR 
spectroscopy; NMR structure determination; disulfide bond isomerization 
 
1. Introduction 
The Naja naja atra chymotrypsin inhibitor (NACI) is a protease inhibitor present in the venom of 
the Taiwan cobra (Naja naja atra). This chymotrypsin inhibitor belongs to the class of non-neurotoxic 
snake Kunitz/BPTI inhibitors [1], which are different from their snake Kunitz/BPTI neurotoxic 
homologues, such as dendrotoxins, calcicludine and the B chain of β-bungarotoxin which act as Ca
2+ 
or K
+ channel blockers [2]. A comparative analysis of the Kunitz/BPTI inhibitors and their neurotoxic 
homologues indicated that residue changes in the active sites result in both conformational adjustment 
and functional divergence [3–5]. The Kunitz domain recognizes one or more proteases through a set of 
10–14 residues that are located mainly in the primary binding loop and partly in the second loop [6]. 
P1, the reactive residue, is located in the primary binding loop, which is important for the binding or 
recognition between the Kunitz domains and proteases. If P1 is Lys or Arg, the protein tends to inhibit 
trypsin, whereas if P1 is Leu, Phe, Tyr, Met, or Trp, the protein tends to inhibit chymotrypsin [7]. The 
second loop also contributes to specificity [6]. Structurally, the second loop is connected to the primary 
binding loop via a disulfide bridge, and together, these loops form an active site that is thought to be 
important for the interaction with the protease. In addition to the P1 residue, residues surrounding the 
active site are important as well. Variable residues located in the weak contact loop provide different 
interactions with various proteases. Hence, these surrounding residues are important for inhibitor 
protease specificity as well [3,7]. 
NACI consists of 57 amino acids, six of which are cysteines. The locations of the six cysteine residues 
are comparable to those of the cysteines in the homologous snake Kunitz/BPTI protein family [3]. 
Because P1 of NACI is Phe, NACI is classified as a chymotrypsin inhibitor. In addition to the P1 
residue, based on the amino acid sequence alignment of NACI with other Kunitz/BPTI protease 
inhibitors, some conserved residues, such as Gly12, Tyr23, Phe33, Tyr35, Gly37, Asn43, and Phe45 
probably play important roles in contact with the protease [3,8]. 
The three-dimensional structure of one chymotrypsin inhibitor, BF9, from the Elapid snake 
Bungarus fasciatus has been reported [5]. BF9 contains 65 amino acids with three disulfide bonds and 
was shown to consist of a double-stranded antiparallel β-sheet and one α-helix. Cys14 of BPTI is 
adjacent to the P1 position, Lys15, and forms a disulfide bond with Cys38, while the corresponding P1 
position in BF9 is Asn17 and the corresponding disulfide bond is Cys16–Cys40 based on sequence 
alignment of BPTI and BF9 [5]. Due to isomerization of the Cys14–Cys38 disulfide bond, two 
conformational isomers with different chirality were observed in BPTI in the NMR spectra [9,10]. The 
population of the two isomers is temperature-dependent. Conformational changes by the Cys14–Cys38 Molecules 2013, 18  8908 
 
 
disulfide bond isomerization cause NMR line broadening. It was reported that some 
1H resonances of 
residues 14–18 in BPTI are broadened at 36 °C and only few NOEs could be assigned [9]. In addition, 
increased transverse 
13C relaxation rates were observed for the C
α resonances of Cys14 and Cys38 [9]. 
Furthermore, it was reported that isomerization of the Cys14 side chain between χ
1 rotamers is faster 
than the corresponding Cys38 isomerization [10].  
2. Results and Discussion 
2.1. Chemical Shift Assignment 
The protein construct used for the structure determination comprised 89 amino acid residues, 
including 32 non-native residues at its N-terminus that are related to the expression system. The   
C-terminal 57 residues constitute the NACI protein, for which 94.8% of the backbone amide protons 
and the non-labile protons were assigned, except residues Ser13 and Ser36–Cys38 as well as H
N of 
Cys14, H
ε1 of His31, and the aromatic protons of Phe45. The overall completeness of resonance 
assignments is well above the threshold required for automated NOESY cross peak assignment [11,12]. 
Among the labile side-chain protons, the ε-proton resonances of all arginine residues and the amide 
groups of asparagine and glutamine residues, except Asn24 and Asn41, were assigned. Several unusual 
chemical shifts were observed in NACI. For example, H
β protons (0.24 and 0.34 ppm) of Pro9 and H
α 
protons (2.90 and 1.65 ppm) of Ile48 and Cys51 were unusually shifted to upfield regions, which was 
also found in the corresponding residues of BF9 [5]. Based on the three-dimensional structure of 
NACI, the observed unusual chemical shifts can be attributed to aromatic ring current effects. Figure 1 
shows a well-dispersed and assigned [
1H,
15N]-HSQC spectrum of NACI. 
Figure 1. Two-dimensional [
15N,
1H]-HSQC spectrum of NACI. Cross peaks are labeled 
with the one letter code and the sequence number of the corresponding amino acid. The 
regions of ε-proton resonances of arginine residues were not decoupled in order to 
distinguish these resonances from other amide proton resonances. 
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The unassigned signals in the HSQC spectrum correspond to the 32 non-native residues that are 
derived from the expression plasmid. Regions from labile side-chain protons of arginine residues were 
not decoupled for the fast identification of the ε-proton resonances. The unassigned signals of the 
backbone amide protons from non-native residues are distributed from about 7.5 to 8.5 ppm, 
suggesting that the non-native residues do not form any well-defined structure. Signals from residues 
around the Cys14–Cys38 disulfide bond are missing, including residues Ser13, Ser36–Cys38, and H
N 
of Cys14. The intensity of the 
13C
β signal of Cys14 is weak, whereas the 
13C
β resonances of the other 
four cysteine residues Cys5, Cys30, Cys51, and Cys55 showed intense signals, which is in agreement 
with the report that increased transverse 
13C relaxation rates were observed for α-carbon resonances of 
residues Cys14 and Cys38 in BPTI [9]. Except for the unassigned 
13C
β resonance of Cys38, the other 
five 
13C
β chemical shifts of Cys5, Cys14, Cys30, Cys51, and Cys55 range from ~39 to ~50 ppm, which 
is consistent with the presence of three disulfide bonds in NACI. 
2.2. Structure Determination and Solution Structure of NaCl 
Excluding the unassigned residues, Ser13 and Ser36–Cys38, about 20 NOE distances restraints per 
residue, including 377 long-range distance restraints between protons five or more residues apart in the 
sequence, were used in the final structure calculation with CYANA [13,14].  
The three-dimensional structure of NACI was examined using PROCHECK-NMR [15] and 
MOLMOL [16]. The 20 energy-minimized conformers are well-defined with RMSD values to the 
mean coordinates of 0.37 Å for the backbone and 0.73 Å for all heavy atoms in the region of residues 
1–57. Table 1 lists structural statistics of the final 20 energy-minimized conformers of NACI. 
Table 1. Structural statistics for the NMR solution structure of NACI. 
NOE distance restraints:   
Number 1075 
Intraresidual, |i – j| = 0  121 
Sequential, |i – j| = 1  324 
Medium range, 1 < |i – j| < 5  253 
Long range, |i – j| >= 5  377 
Maximal violation  0.10 ± 0.01 Å 
Torsion angle restraints (ϕ/ψ):  
Number 75 
Maximal violation  2.94 ± 0.87° 
Final CYANA target function value  2.61 ± 1.61 Å
2 
AMBER energy  −2208 ± 50 kcal/mol 
RMSDs from ideal geometry:   
Bond lengths  0.015 ± 0.001 Å 
Bond angles  1.93 ± 0.04° 
RMSD to mean coordinates of residues 1–57:   
Backbone atoms N, C
α, C'  0.37 ± 0.08Å 
All heavy atoms  0.73 ± 0.08Å 
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Table 1. Cont. 
NOE distance restraints:   
PROCHECK Ramachandran plot statistics:   
Most favorable regions  78.5% 
Additional allowed regions  21.5% 
Generously allowed regions  0.0% 
Disallowed regions  0.0% 
All (φ,ψ) backbone torsion angle pairs were found in the most favored or additionally allowed 
regions of the Ramachandran plot. NACI is an α/β protein with one α-helix (Ile48–Cys55) and two  
β-strands (Val18–Asn24 and Thr29–Tyr35) (Figure 2a). These two β-strands are arranged antiparallel 
as a β-sheet. In addition, Arg3–Glu6 form a 310-helix. The ensembles fitted to the regions of secondary 
structure elements, residues 3–6, 18–24, 29–35 and 48–55, are shown in Figure 2b and c. The solution 
structure of NACI and the conformational restraints were deposited in the Protein Data Bank with 
accession code 2M99. The chemical shifts were deposited in the Biological Magnetic Resonance Data 
Bank (BMRB) [17] with accession number 19287. 
Figure 2. NMR solution structure of NACI. (a) Ribbon diagram of NACI.   
(b) Superposition of the backbone atoms of the 20 conformers that represent the solution 
structure of NACI for best fit of the backbone atoms N, C
α, C’ in the secondary structure 
regions, residues 3–6, 18–24, 29–35, and 48–55. Residues Ser13–Cys14 and Ser36–Cys38 
around the Cys14–Cys38 disulfide bond are not well defined due to missing resonances 
and indicated in red. (c) Side chains of Ser13–Cys14 and Ser36–Cys38 are shown in red, 
aromatic residues (F4, F15, F17, Y21, Y22, Y23, Y26, F33, Y35, F45) in magenta, and 
hydrophobic residues (Ala, Val, Leu, Ile, Thr, Pro) in green. 
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In order to investigate the structural character of NACI, the secondary structures of NACI were 
compared with those in BPTI and BF9 based on sequence alignment by ClustalW2 (Figure 3a). NACI 
shows similar secondary structure elements as BPTI and BF9. With regard to the similarity of the 
three-dimensional fold between NACI and its homologues, comparisons of the solution structure of 
NACI with BPTI [18] and BF9 [5] showed that the RMSD values, calculated for the backbone atoms 
N, C
α, and C’ in the secondary structure regions, between mean coordinates of NACI and its homologues 
are 1.09 Å for BPTI (PDB code: 1PIT) and 1.27 Å for BF9 (PDB code: 1JC6) (Figure 3b and c), 
indicating that NACI adopts a similar fold as BPTI and BF9. In particular, Figure 3b and c show that 
all three proteins share not only similar secondary structures but also the same tertiary fold. 
Figure 3. Sequence and structure comparison of NACI with homologues. (a) Sequence 
alignment of NACI with BF9 and BPTI. The secondary structure elements for NACI, BF9, 
and BPTI are shown in blue (β-strands) and red (helices). Disulfide bonds are shown with 
black lines. The arrow indicates the P1 residue. (b) Structural comparison between the 
mean structures of NACI (blue) and the BPTI (green). (c) Structural comparison between 
the mean structures of NACI (blue) and the BF9 (green). 
 
Figure 4 compares residue-residue interactions between NACI and BPTI, and between NACI and 
BF9 for the conserved aromatic, hydrophobic, charged and polar amino acids. The side chain 
orientations of most conserved residues in NACI and BPTI as well as in NACI and BF9 coincide with Molecules 2013, 18  8912 
 
 
each other, which suggests that the residue-residue interactions in NACI and BPTI as well as in NACI 
and BF9 are similar. 
Figure 4. Comparison of residue-residue interactions between (a) NACI (blue) and BPTI 
(magenta) and (b) NACI (blue) and BF9 (green). Residues 1, 2, 4, 5, 8, 9, 11, 12, 14, 16, 
18, 19, 21, 22, 23, 24, 30, 31, 33, 35, 37, 38, 43, 45, 46, 47, 48, 49, 50, 51, 53, 54, and 55 
in NACI and BPTI as well as the corresponding residues in BF9 are shown.  
 
NACI contains ten Tyr and Phe residues. Three of these side chains, Phe15, Phe17, and Phe45, are 
not converged to a defined conformation (Figure 2c). The disorder of the Phe45 side chain is due to 
missing ring resonances. The other two residues, Phe15, Phe17, as well as Tyr26, are not conserved 
based on the sequence alignment and point outside toward the solvent (Figure 2c), while the other 
seven Tyr and Phe residues are conserved as aromatic residues among NACI, BPTI, and BF9   
(Figure 3a). Phe15, Phe17, and Tyr26 in NACI correspond to Asn17, Leu19, and His28 in BF9, and 
Lys15, Arg17, and Lys26 in BPTI. Comparisons of the side chain orientation of the three 
corresponding residues in BPTI, BF9 and NACI show that all these side chains in BF9 and BPTI point 
outside toward the solvent rather than into the interior of the proteins and do not show a well-defined 
conformation (Figure 5), which suggests that the three aromatic residues Phe15, Phe17, and Tyr26 are 
not essential for stabilizing the fold of NACI. 
The functional site for the protease inhibitory activity is located in the binding loops. It was 
reported that BPTI binds to trypsin with residues 11–19, 34, and 36–39 [19]. Figure 6 shows that the 
backbone conformations of the binding loops in BPTI (magenta), NACI (blue), and BF9 (green) are 
similar, suggesting that the amino acid side chains in the binding loop regions might play an important 
role for the different inhibitory specificity of the three proteins. Molecules 2013, 18  8913 
 
 
Figure 5. Side chain conformations of Phe15, Phe17, and Tyr26 in NACI (blue), and of 
corresponding residues in homologous structures. i.e., Lys15, Arg17, and Lys26 in BPTI 
(green) and Asn17, Leu19, and His28 in BF9 (magenta). (a) Phe15 in NACI, Lys15 in 
BPTI, and Asn17 in BF9. (b) Phe17 in NACI, Arg17 in BPTI, and Leu19 in BF9.   
(c) Tyr26 in NACI, Lys26 in BPTI, and His28 in BF9.  
 
Figure 6. Backbone conformation of residues 11–19, 34, and 36–39 in the trypsin binding 
loop of BPTI (magenta), and corresponding residues in NACI (blue) and BF9 (green). 
 
Figure 7 shows the side chains in the binding loops, residues 11–19, 34, and 36–39. Ser13, Phe15, 
Phe17, Thr34, Ser36, and Gly39 in NACI (blue), corresponding to Pro13, Lys15, Arg17, Val34, Gly36, 
and Arg39 in BPTI (magenta), and Arg 15, Asn17, Leu19, Asn36, Gly38, and Gly41 in BF9 (green), 
are not conserved based on the sequence alignment (Figure 3a). Most side chains of these non-conserved 
residues, except Thr34 and Ser36, do not show a well-defined conformation (Figure 7a), which Molecules 2013, 18  8914 
 
 
suggests that these residues might be involved in specificity, whereas Thr34 and Ser36 in NACI might 
participate in stabilizing a local conformation or contact with protease. 
Figure 7. Side chains of residues 11–19, 34, and 36–39 in the trypsin binding loops of 
BPTI (magenta) and corresponding residues in NACI (blue) and BF9 (green). (a) Side 
chains of non-conserved residues. (b) Side chains of conserved residues.  
 
In BPTI an interior water molecule is located near the Cys14–Cys38 disulfide bond where it forms 
a hydrogen bond with the carbonyl-oxygen of Cys38, whereas in BPTI(G36S), conserved also as 
Ser36 in NACI, the hydroxyl side chain of Ser36 replaces the internal water molecule and forms 
hydrogen bonds with the same partners [9]. The non-conserved Ser36 in NACI might be involved in 
maintaining a certain conformation by a similar pattern as in the BPTI(G36S) mutant. 
In contrast, the side chain conformations of the conserved residues are better converged (Figure 7b), 
except for residues 14, 37–38 in NACI and BPTI as well as 16, 39–40 in BF9, which is around  
Cys14–Cys38/Cys16–Cys40 disulfide bond region. The disorder of these conserved residues is 
probably due to isomerization of the Cys14–Cys38/Cys16–Cys40 disulfide bond. 
One reported characteristic feature of the BPTI structure is the Cys14–Cys38 disulfide bond region, 
in which Cys14 is located in the primary binding loop and Cys38 in the second loop. It was reported 
that two conformational isomers due to isomerization of the Cys14–Cys38 disulfide bond were observed in 
BPTI and that the population of the minor form is 1.5% at 4 °C and increases to 8% at 68 °C [9]. In the 
NACI structure, regions around the Cys14–Cys38 disulfide bond are not well defined due to missing 
chemical shifts of residues Ser13–Cys14 and Ser36–Cys38 (Figure 2b and c). In addition, although H
α 
and H
β protons of Cys14 could be assigned, totally only two NOE restraints were assigned to Cys14, 
significantly less than the average of 20 NOE restraints per residue. The observed significant line 
broadening at 22 °C is confined to a small region around the Cys14–Cys38 disulfide bond, i.e., 
residues Ser13–Cys14 and Ser36–Cys38, rather than being extended to longer segments in the primary 
binding loop and/or in the second loop, suggesting that the line broadening in NACI might result from 
conformational exchange around the Cys14–Cys38 disulfide bond. As reported in BPTI, isomerization 
of the Cys14–Cys38 disulfide bond might also exist in NACI.  
In an attempt to avoid the severe line broadening and to observe the signals from the major and 
minor conformers of the Ser13–Cys14 and Ser36–Cys38 residues, we measured HSQC spectra at Molecules 2013, 18  8915 
 
 
different temperatures, 4, 10, 14, 22, 30, and 37 °C. It was reported that the population of the minor 
form in BPTI(G36S) is about 15%, i.e., higher than in wild-type BPTI, and increases at higher 
temperatures [9]. NACI possesses also Ser36, as BPTI(G36S), suggesting that NACI might contain a 
higher population of the minor form than BPTI. Comparing HSQC spectra of NACI recorded at 
different temperatures showed that, in addition to some weak signals, few additional signals appeared, 
precluding assignments of a minor form. 
3. Experimental  
3.1. Sample Preparation  
Recombinant NACI was obtained by overexpression in Escherichia coli. Protein expression and 
purification were described elsewhere [3]. The protein was uniformly labeled with 
15N and 
13C by 
growing bacteria on an isotope-enriched minimal medium using 
15N ammonium chloride and 
13C-enriched 
glucose as the principal nitrogen and carbon sources, respectively. NMR samples of purified protein 
(1–2 mM) were prepared in a buffer containing 50 mM sodium phosphate at pH 3.0 and 10% v/v 
2H2O [5]. 
The pH value was chosen in agreement with that for the solution structure determination of the 
homologous chymotrypsin inhibitor BF9 [5], for which complete resonance assignments could not be 
obtained at neutral pH due to several missing backbone and side chain amide protons. In addition, BF9 
was reported to possess similar conformations at different pH values [5]. The NACI protein sample 
was prepared by refolding before lowering the pH value to 3.0. Therefore the disulfide bonds had 
already formed when the pH was decreased to 3.0. The recombinant protein used for the NMR 
measurements comprised 89 amino acid residues. The C-terminal 57 residues corresponded to the 
Taiwan cobra chymotrypsin inhibitor, whereas the 32 non-native N-terminal residues were derived 
from the expression plasmid [3]. In principle, the N-terminal extension could be removed by thrombin 
cleavage. However, this was not done because it had been shown earlier [3] that only a marginal 
amount of NACI could be obtained after thrombin digestion and that the protein with the N-terminal 
extension was functional. The binding affinities of NACI to α-chymotrypsin were previously reported 
to be Ki = 180 and 133 nM with and without the N-terminal fused peptide, respectively [3].  
3.2. NMR Measurements  
The backbone assignment was based on 3D HNCACB, CBCA(CO)NH, HN(CA)CO, HCACO 
HBHA(CO)NH, and 2D 
15N/
1H-HSQC spectra. Side-chain 
1H and 
13C resonances were derived from 
3D C(CO)NH and H(C)CH-TOCSY as well as heteronuclear 2D 
13C/
1H-CB(CGCD)HD and   
13C/
1H-CB(CGCDCE)HE. Homonuclear 2D NOESY and 3D 
15N-resolved NOESY with 200 ms mixing 
time [5] were collected for protein structure determination. Spectra were recorded at 22 °C on a Varian 
VNMRS 600 MHz NMR spectrometer equipped with a 
1H, 
15N, 
13C triple resonance probe head. The 
software packages VnmrJ and Sparky [20] were used for data processing and interactive spectra 
analysis, respectively. 
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3.3. Structure Calculation  
Peak lists for the NOESY spectra were obtained by interactive peak picking with the program 
Sparky. The three-dimensional structure was determined by combined automated NOESY cross peak 
assignment [11] and structure calculation with torsion angle dynamics [13] implemented in the 
program CYANA [21]. Information of α-helices and β-strands were obtained from chemical shift 
index (CSI) analysis [22]. Restraints for hydrogen bonds involved in regular secondary structures were 













j+1 NOE cross peaks between different β-strands were observed. The disulfide bonds used 
in the structure calculations were Cys5–Cys55, Cys14–Cys38, and Cys30–Cys51. Backbone torsion 
angle restraints were obtained with the program TALOS [23]. The standard CYANA protocol of seven 
iterative cycles of NOE assignment and structure calculation, followed by a final structure calculation, 
was applied. In each cycle the structure calculation started from 100 randomized conformers, and 8000 
torsion angle dynamics steps were performed per conformer. The 20 conformers with the lowest final 
CYANA target function values were subjected to restrained energy refinement in explicit solvent 
against the AMBER force field [24] using the program OPALp [25,26]. 
4. Conclusions 
The solution structure of the Naja naja atra chymotrypsin inhibitor (NACI) was determined by NMR. 
NACI shows similar secondary structure as two other serine protease inhibitors, the bovine pancreatic 
trypsin inhibitor (BPTI) and the Bungarus fasciatus fraction IX (BF9). Also their three-dimensional 
structures coincide closely with RMSD values of 1.09 Å between NACI and BPTI and 1.27 Å between 
NACI and BF9. In addition, broadening of resonances observed in NACI at 22 °C for residues   
Ser13–Cys14 and Ser36–Cys38, a region around the Cys14–Cys38 disulfide bond, suggests 
isomerization of the Cys14–Cys38 disulfide bond as reported for BPTI. 
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